Antimicrobial Innovation: How Zonova is Changing Healthcare from the Inside Out
The Innovation Conversation · Ricardo Pascual
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🎙️ Innotion Conversation: Fighting Infection with Innovation — Zonova’s Journey in Health Tech
In this episode of Innotion Conversation, host Ricardo Pascual speaks with Dr. Georgia Fleet and Carla Southworth, co-founders of Zonova, about their mission to reduce hospital-acquired infections through groundbreaking antimicrobial technology.
They discuss:
- The global challenge of antimicrobial resistance.
- Feedback from the healthcare market on infection control.
- Navigating regulatory hurdles and manufacturing plans.
- The realities of building investor relationships in early-stage startups.
- Broader applications of antimicrobial technologies beyond medical devices.
- Key advice for aspiring entrepreneurs in health tech.
Tune in to hear how innovation, persistence, and a clear mission are helping transform healthcare solutions.
Brought to you by Startup Summit 2025 — Europe’s leading startup and investor summit, happening September 18–19, 2025, in Lisbon.
🎟️ Learn more and secure your spot at www.startupsummit.io
🕒 Chapters 00:00 — Introduction to Zonova and Its Founders 03:02 — The Problem of Hospital-Acquired Infections 05:52 — Founding Journey 09:01 — Market Feedback and Antimicrobial Resistance 12:14 — Regulatory Challenges and Manufacturing Plans 15:00 — Investor Relations and Startup Challenges 18:03 — Broader Applications of Antimicrobial Technology 21:02 — Personal Experiences and Advice for Entrepreneurs
💡 Key Takeaways
- Zonova aims to reduce hospital-acquired infections with novel antimicrobial technology.
- 75% of catheterized patients experience urinary tract infections.
- The founding journey is challenging but highly rewarding.
- Market feedback shows strong demand for effective infection control.
- Antimicrobial resistance is an escalating global health crisis.
- Regulatory pathways vary by region, complicating market access.
- Building investor relationships requires resilience and adaptability.
- Experienced advisors are essential for startup success.
- Antimicrobial technologies have potential beyond medical devices.
- Entrepreneurship demands patience and a long-term vision.